1. Long‐term follow‐up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B–cell non‐Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU). Issue 10 (17th August 2017) Authors: Witzig, Thomas E.; Johnston, Patrick B.; LaPlant, Betsy R.; Kurtin, Paul J.; Pederson, Levi D.; Moore Jr, Dennis F.; Nabbout, Nassim H.; Nikcevich, Daniel A.; Rowland, Kendrith M.; Grothey, Axel Journal: American journal of hematology Issue: Volume 92:Issue 10(2017:Oct.) Page Start: 1004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗